PREVENTION AND TREATMENT OF BENIGN PROSTATIC HYPERPLASIA USING A SELECTIVE INHIBITOR OF THE PRODUCTION OF REACTIVE OXYGEN SPECIES OF MITOCHONDRIAL ORIGIN

摘要

The present invention concerns the prevention and/or treatment of diseases in which reactive oxygen species (or ROSs) of mitochondrial origin are involved. It relates more particularly to the use of an inhibitor of mitochondrial ROS production, in particular of anethole trithione, for the prevention and/or treatment of benign prostatic hyperplasia.